Company Performance: Exo Technologies' financial health, including revenue growth, profitability, and debt levels, significantly influences investor confidence and stock price.

Market Sentiment: Overall investor mood and economic outlook impact demand for risk assets like stocks. Positive sentiment can drive prices up, while negative sentiment can depress them.

Sector Trends: Developments within the healthcare technology sector, such as regulatory changes, technological advancements, and competitor performance, affect Exo's valuation.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and GDP growth impact investor risk appetite and company earnings, ultimately affecting the stock price.

News & Announcements: Company-specific news, such as product launches, clinical trial results, partnerships, and acquisitions, can trigger significant price fluctuations.

Exchange Rates: As a UK-listed stock, currency fluctuations can affect the attractiveness of 0EXO.LSE to international investors.

Regulatory Environment: Changes in healthcare regulations, particularly those affecting Exo's products and services, can impact the company's future prospects and stock price.

Investor Relations: Effective communication with investors, including transparency about company strategy and financial performance, can build confidence and support the stock price.

Technological Innovation: Exo's ability to develop and commercialize innovative healthcare technologies is crucial for long-term growth and investor interest.

Competition: The competitive landscape, including the presence of established players and emerging competitors, affects Exo's market share and profitability.